Inspired? If you’re an Early Career Researcher you could win a £300 grant to share your research at an academic conference. Deadlines are rolling on a monthly basis.

Apply now

Convalescent plasma (CP) therapy to treat hospitalised COVID-19 patients has received emergency use authorisation (EUA) from the FDA in the United States. This kind of therapy is a classic prevention and treatment strategy against infectious diseases that has been in use for many decades.

Read More

‘Convalescent plasma therapy’ (CPT) – using the antibody-containing blood components of recovered COVID-19 patients – could be an effective treatment for people critically sick with the disease.

Read More

Posts by Tag

see all